Volume 14, Number 8—August 2008

Research

Interepidemic Rift Valley Fever Virus Seropositivity, Northeastern Kenya

A. Desiree LaBeaud*† , Eric M. Muchiri‡, Malik Ndzovu‡, Mariam T. Mwanje‡, Samuel Muiruri‡, Clarence J. Peters§, and Charles H. King†

Author affiliations: *Rainbow Babies and Children’s Hospital, Cleveland, Ohio, USA; †Case Western Reserve University Center for Global Health and Diseases, Cleveland; ‡Ministry of Health, Nairobi, Kenya; §University of Texas Medical Branch, Galveston, Texas, USA;

Main Article

Figure 4

Figure 4. Rift Valley fever virus immunoglobulin G seropositivity by decade of age and village of residence; Gumarey had a higher rate than Sogan-Godud in almost all age groups.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.